Ana Babic Perhoc
Overview
Explore the profile of Ana Babic Perhoc including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
99
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Osmanovic Barilar J, Papic V, Farkas V, Rubic I, Meglic P, Bagaric R, et al.
Neuropharmacology
. 2024 Dec;
265:110246.
PMID: 39643239
Parkinson's disease (PD) is a highly heterogeneous and therefore a possible cause of translation failure of drugs from animal testing to human treatments can be because existing models cannot replicate...
2.
Homolak J, Varvaras K, Sciacca V, Babic Perhoc A, Virag D, Knezovic A, et al.
ACS Omega
. 2024 Mar;
9(10):11288-11304.
PMID: 38496956
Recent evidence suggests that the gut plays a vital role in the development and progression of Alzheimer's disease (AD) by triggering systemic inflammation and oxidative stress. The well-established rat model...
3.
Homolak J, Joja M, Grabaric G, Schiatti E, Virag D, Babic Perhoc A, et al.
Mol Neurobiol
. 2024 Jan;
61(8):5481-5493.
PMID: 38200352
The gut-brain axis plays an important role in Parkinson's disease (PD) by acting as a route for vagal propagation of aggregated α-synuclein in the gut-first endophenotype and as a mediator...
4.
Homolak J, Babic Perhoc A, Virag D, Knezovic A, Osmanovic Barilar J, Salkovic-Petrisic M
Bioessays
. 2023 Dec;
46(2):e2300061.
PMID: 38058119
Sarcopenia is a process of progressive aging-associated loss of skeletal muscle mass (SMM) recognized as a serious global health issue contributing to frailty and increased all-cause mortality. Exercise and nutritional...
5.
Homolak J, Babic Perhoc A, Knezovic A, Osmanovic Barilar J, Virag D, Salkovic-Petrisic M
ACS Chem Neurosci
. 2023 Nov;
14(22):4013-4025.
PMID: 37932005
The gut might play an important role in the etiopathogenesis of Alzheimer's disease (AD) as gastrointestinal alterations often precede the development of neuropathological changes in the brain and correlate with...
6.
Homolak J, De Busscher J, Zambrano-Lucio M, Joja M, Virag D, Babic Perhoc A, et al.
ACS Chem Neurosci
. 2023 Jul;
14(15):2667-2682.
PMID: 37477640
The gastrointestinal (GI) system is affected in Alzheimer's disease (AD); however, it is currently unknown whether GI alterations arise as a consequence of central nervous system (CNS) pathology or play...
7.
Homolak J, Babic Perhoc A, Virag D, Knezovic A, Osmanovic Barilar J, Salkovic-Petrisic M
J Radiat Res
. 2023 Jun;
64(4):743-745.
PMID: 37312584
No abstract available.
8.
Osmanovic Barilar J, Babic Perhoc A, Knezovic A, Homolak J, Virag D, Salkovic-Petrisic M
Biomedicines
. 2023 May;
11(4).
PMID: 37189641
Type 2 diabetes mellitus increases the risk of sporadic Alzheimer's disease (sAD), and antidiabetic drugs, including the sodium-glucose cotransporter inhibitors (SGLTI), are being studied as possible sAD therapy. We have...
9.
Knezovic A, Piknjac M, Osmanovic Barilar J, Babic Perhoc A, Virag D, Homolak J, et al.
Biomedicines
. 2023 Mar;
11(3).
PMID: 36979662
Cognitive deficit is a frequent non-motor symptom in Parkinson's disease (PD) with an unclear pathogenesis. Recent research indicates possible involvement of insulin resistance and glutamate excitotoxicity in PD development. We...
10.
Grunblatt E, Homolak J, Babic Perhoc A, Davor V, Knezovic A, Osmanovic Barilar J, et al.
Front Neurosci
. 2023 Mar;
17:1104985.
PMID: 36875654
Alzheimer's disease (AD) is the most common neurodegenerative disorder with the majority of patients classified as sporadic AD (sAD), in which etiopathogenesis remains unresolved. Though sAD is argued to be...